Last updated: February 25, 2026
What is the excipient profile of Amazon Basic Care Ibuprofen PM?
Amazon Basic Care Ibuprofen PM contains active ingredients of 200 mg ibuprofen and 25 mg diphenhydramine hydrochloride per tablet. Its excipient list typically includes film coating agents, binders, fillers, disintegrants, and lubricants. Common excipients in OTC pain relief and sleep aid formulations are:
- Microcrystalline cellulose (filler, binder)
- Magnesium stearate (lubricant)
- Hypromellose (film coating)
- Titanium dioxide (film coating)
- Polyethylene glycol (disintegrant and solubilizer)
- Povidone (binder)
Exact excipient composition remains proprietary, but aligns with standard OTC analgesic and sleep aid formulations. Such excipients support stability, bioavailability, manufacturing processability, and patient safety.
How does excipient selection impact product differentiation?
Excipient choice influences:
- Shelf life: Stabilizes active ingredients and prevents degradation.
- Bioavailability: Ensures rapid decision of active drug upon ingestion.
- Sensory attributes: Affects swallowing experience, taste, and mouthfeel.
- Allergenicity & Tolerability: Use of hypoallergenic, non-irritant excipients minimizes adverse reactions.
In OTC products, excipient strategies are crucial for compliance and consumer perception.
What are key commercial opportunities related to excipient strategy?
-
Formulation Innovation:
- Developing controlled-release formulations or incorporating novel excipients (e.g., bioadhesive polymers) can extend product differentiation.
- Use of excipients to mask unpleasant tastes or improve mouthfeel enhances consumer satisfaction.
-
Allergen Reduction and Tolerance:
- Replacing common excipients like lactose with allergen-free alternatives broadens target markets, particularly for lactose-intolerant consumers.
-
Stability and Shelf Life Extension:
- Using excipients that improve stability prolongs shelf life, reducing waste and inventory costs.
-
Manufacturing Efficiency:
- Selecting excipients compatible with high-speed manufacturing processes reduces costs and increases output.
-
Regulatory and Patent Considerations:
- Innovative excipient combinations can serve as patentable formulation claims, protecting market share.
-
Market Expansion via Tailored Formulations:
- Targeting specific demographics (e.g., elderly, children) with age-appropriate excipients (e.g., lower excipient volume, non-irritating agents).
How do excipient choices compare across OTC pain and sleep products?
| Feature |
Amazon Basic Care Ibuprofen PM |
Competing Brands (e.g., Tylenol PM, Advil PM) |
| Active Ingredients |
Ibuprofen, diphenhydramine |
Acetaminophen or ibuprofen, diphenhydramine or doxylamine |
| Typical Excipients |
Microcrystalline cellulose, magnesium stearate, hypromellose |
Similar fillers, lubricants, film coatings; some include flavoring agents |
| Shelf Stability |
High due to inert excipients |
Similar, with minor variations based on formulation |
| Tolerance |
Non-irritant excipients used |
Similar; some brands add flavorings or sweeteners |
What regulatory considerations impact excipient strategies?
- FDA Compliance: OTC monographs limit certain excipients and require safety data.
- GRAS Status: Excipients must adhere to Generally Recognized As Safe standards.
- Novel Excipient Approval: Use of new excipients necessitates supplemental safety data.
- Labeling: Accurate disclosure of excipients, especially allergens.
Can innovation in excipients create new market segments?
Yes. Incorporating advanced delivery technologies—such as bioadhesive polymers, taste-masking agents, or microencapsulation—can facilitate the launch of differentiated products targeted at specific patient groups. These innovations can unlock premium pricing and expand consumer base.
Summary of key points
| Aspect |
Details |
| Formulation |
Standard OTC analgesic with sleep aid components; excipient profile typical for formulation stability and consumer experience. |
| Differentiation |
Excipients influence stability, tolerability, palatability, and ease of manufacturing. |
| Market opportunities |
Innovation in controlled-release, allergen reduction, stability, and tailored formulations. |
| Regulatory |
Excipients must meet FDA regulations and GRAS status; novel excipients require approval. |
| Competitive landscape |
Similar excipient use across brands, with potential for differentiation through formulation innovation. |
Key Takeaways
- Excipient choice directly influences product stability, tolerability, and consumer acceptance.
- Formulation innovation via excipients offers potential to expand market share and create premium products.
- Regulatory compliance remains a key factor in excipient selection.
- Substituting allergen-containing excipients with hypoallergenic alternatives broadens market access.
- Advanced delivery systems and tailored excipient profiles can differentiate Amazon Basic Care Ibuprofen PM in a competitive OTC space.
FAQs
1. What excipients are most critical for OTC pain relief products?
Stability, bioavailability, and tolerability are prioritized. Common excipients include microcrystalline cellulose, magnesium stearate, and hypromellose.
2. How do excipient choices influence product shelf life?
Inert and stabilizing excipients prevent active ingredient degradation, extending shelf life and reducing waste.
3. What opportunities exist for excipient innovations in OTC sleep aids?
Taste-masking agents, controlled-release polymers, and improved disintegration profiles help differentiate products and improve consumer satisfaction.
4. Can novel excipients be used in OTC formulations?
Yes, but they require regulatory approval and safety data submissions, which increase product development timelines and costs.
5. How does Amazon Basic Care leverage excipient strategies to compete?
By employing standard, proven excipients to ensure safety, stability, and cost-effectiveness, with room for future innovation to create differentiated formulations.
References
[1] U.S. Food and Drug Administration. (2022). Guidance for Industry: Nonprescription Drugs — OTC Monograph Process.
[2] USP. (2021). USP-NF General Chapters—Excipients.
[3] European Medicines Agency. (2020). Guideline on excipients in pharmaceuticals.
[4] Mehta, R. (2018). Advances in formulation strategies for OTC drugs. Journal of Pharmaceutical Sciences, 107(6), 1574-1581.
[5] Smith, J. (2020). OTC drug excipient regulatory requirements. PharmTech.
